According to our latest study, the global Pharmacovigilance Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmacovigilance Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmacovigilance Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmacovigilance Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmacovigilance Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmacovigilance Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmacovigilance Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmacovigilance Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PrimeVigilance, Quanticate, ProPharma, Parexel and Accenture, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmacovigilance Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adverse Event Case Management
Aggregate Reporting
Signal Intelligence
Risk Management
Market segment by Application
Biotechnology and Pharmaceuticals
Contract Research Organization
Hospital
KPO / BPO
Healthcare Institutions
Others
Market segment by players, this report covers
PrimeVigilance
Quanticate
ProPharma
Parexel
Accenture
SOTERIUS
SGS
Medpace
PPD
QVigilance
Freyr Solutions
Navitas Life Sciences
MMS Holdings
Amarex
Astrix Technology Group
Cambridge Regulatory Services
CROMSOURCE
APCER Life Sciences
Pharmya
A+Science
Midas Pharma
George Clinical
Syneos Health
INPHARMATIS
Taimei Technology
Extedo
WCG Clinical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmacovigilance Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmacovigilance Services, with revenue, gross margin and global market share of Pharmacovigilance Services from 2018 to 2023.
Chapter 3, the Pharmacovigilance Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmacovigilance Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacovigilance Services.
Chapter 13, to describe Pharmacovigilance Services research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Pharmacovigilance Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmacovigilance Services by Type
1.3.1 Overview: Global Pharmacovigilance Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmacovigilance Services Consumption Value Market Share by Type in 2022
1.3.3 Adverse Event Case Management
1.3.4 Aggregate Reporting
1.3.5 Signal Intelligence
1.3.6 Risk Management
1.4 Global Pharmacovigilance Services Market by Application
1.4.1 Overview: Global Pharmacovigilance Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biotechnology and Pharmaceuticals
1.4.3 Contract Research Organization
1.4.4 Hospital
1.4.5 KPO / BPO
1.4.6 Healthcare Institutions
1.4.7 Others
1.5 Global Pharmacovigilance Services Market Size & Forecast
1.6 Global Pharmacovigilance Services Market Size and Forecast by Region
1.6.1 Global Pharmacovigilance Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmacovigilance Services Market Size by Region, (2018-2029)
1.6.3 North America Pharmacovigilance Services Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmacovigilance Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmacovigilance Services Market Size and Prospect (2018-2029)
1.6.6 South America Pharmacovigilance Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmacovigilance Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 PrimeVigilance
2.1.1 PrimeVigilance Details
2.1.2 PrimeVigilance Major Business
2.1.3 PrimeVigilance Pharmacovigilance Services Product and Solutions
2.1.4 PrimeVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 PrimeVigilance Recent Developments and Future Plans
2.2 Quanticate
2.2.1 Quanticate Details
2.2.2 Quanticate Major Business
2.2.3 Quanticate Pharmacovigilance Services Product and Solutions
2.2.4 Quanticate Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Quanticate Recent Developments and Future Plans
2.3 ProPharma
2.3.1 ProPharma Details
2.3.2 ProPharma Major Business
2.3.3 ProPharma Pharmacovigilance Services Product and Solutions
2.3.4 ProPharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ProPharma Recent Developments and Future Plans
2.4 Parexel
2.4.1 Parexel Details
2.4.2 Parexel Major Business
2.4.3 Parexel Pharmacovigilance Services Product and Solutions
2.4.4 Parexel Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Parexel Recent Developments and Future Plans
2.5 Accenture
2.5.1 Accenture Details
2.5.2 Accenture Major Business
2.5.3 Accenture Pharmacovigilance Services Product and Solutions
2.5.4 Accenture Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Accenture Recent Developments and Future Plans
2.6 SOTERIUS
2.6.1 SOTERIUS Details
2.6.2 SOTERIUS Major Business
2.6.3 SOTERIUS Pharmacovigilance Services Product and Solutions
2.6.4 SOTERIUS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SOTERIUS Recent Developments and Future Plans
2.7 SGS
2.7.1 SGS Details
2.7.2 SGS Major Business
2.7.3 SGS Pharmacovigilance Services Product and Solutions
2.7.4 SGS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 SGS Recent Developments and Future Plans
2.8 Medpace
2.8.1 Medpace Details
2.8.2 Medpace Major Business
2.8.3 Medpace Pharmacovigilance Services Product and Solutions
2.8.4 Medpace Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Medpace Recent Developments and Future Plans
2.9 PPD
2.9.1 PPD Details
2.9.2 PPD Major Business
2.9.3 PPD Pharmacovigilance Services Product and Solutions
2.9.4 PPD Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PPD Recent Developments and Future Plans
2.10 QVigilance
2.10.1 QVigilance Details
2.10.2 QVigilance Major Business
2.10.3 QVigilance Pharmacovigilance Services Product and Solutions
2.10.4 QVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 QVigilance Recent Developments and Future Plans
2.11 Freyr Solutions
2.11.1 Freyr Solutions Details
2.11.2 Freyr Solutions Major Business
2.11.3 Freyr Solutions Pharmacovigilance Services Product and Solutions
2.11.4 Freyr Solutions Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Freyr Solutions Recent Developments and Future Plans
2.12 Navitas Life Sciences
2.12.1 Navitas Life Sciences Details
2.12.2 Navitas Life Sciences Major Business
2.12.3 Navitas Life Sciences Pharmacovigilance Services Product and Solutions
2.12.4 Navitas Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Navitas Life Sciences Recent Developments and Future Plans
2.13 MMS Holdings
2.13.1 MMS Holdings Details
2.13.2 MMS Holdings Major Business
2.13.3 MMS Holdings Pharmacovigilance Services Product and Solutions
2.13.4 MMS Holdings Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 MMS Holdings Recent Developments and Future Plans
2.14 Amarex
2.14.1 Amarex Details
2.14.2 Amarex Major Business
2.14.3 Amarex Pharmacovigilance Services Product and Solutions
2.14.4 Amarex Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Amarex Recent Developments and Future Plans
2.15 Astrix Technology Group
2.15.1 Astrix Technology Group Details
2.15.2 Astrix Technology Group Major Business
2.15.3 Astrix Technology Group Pharmacovigilance Services Product and Solutions
2.15.4 Astrix Technology Group Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Astrix Technology Group Recent Developments and Future Plans
2.16 Cambridge Regulatory Services
2.16.1 Cambridge Regulatory Services Details
2.16.2 Cambridge Regulatory Services Major Business
2.16.3 Cambridge Regulatory Services Pharmacovigilance Services Product and Solutions
2.16.4 Cambridge Regulatory Services Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Cambridge Regulatory Services Recent Developments and Future Plans
2.17 CROMSOURCE
2.17.1 CROMSOURCE Details
2.17.2 CROMSOURCE Major Business
2.17.3 CROMSOURCE Pharmacovigilance Services Product and Solutions
2.17.4 CROMSOURCE Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 CROMSOURCE Recent Developments and Future Plans
2.18 APCER Life Sciences
2.18.1 APCER Life Sciences Details
2.18.2 APCER Life Sciences Major Business
2.18.3 APCER Life Sciences Pharmacovigilance Services Product and Solutions
2.18.4 APCER Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 APCER Life Sciences Recent Developments and Future Plans
2.19 Pharmya
2.19.1 Pharmya Details
2.19.2 Pharmya Major Business
2.19.3 Pharmya Pharmacovigilance Services Product and Solutions
2.19.4 Pharmya Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Pharmya Recent Developments and Future Plans
2.20 A+Science
2.20.1 A+Science Details
2.20.2 A+Science Major Business
2.20.3 A+Science Pharmacovigilance Services Product and Solutions
2.20.4 A+Science Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 A+Science Recent Developments and Future Plans
2.21 Midas Pharma
2.21.1 Midas Pharma Details
2.21.2 Midas Pharma Major Business
2.21.3 Midas Pharma Pharmacovigilance Services Product and Solutions
2.21.4 Midas Pharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Midas Pharma Recent Developments and Future Plans
2.22 George Clinical
2.22.1 George Clinical Details
2.22.2 George Clinical Major Business
2.22.3 George Clinical Pharmacovigilance Services Product and Solutions
2.22.4 George Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 George Clinical Recent Developments and Future Plans
2.23 Syneos Health
2.23.1 Syneos Health Details
2.23.2 Syneos Health Major Business
2.23.3 Syneos Health Pharmacovigilance Services Product and Solutions
2.23.4 Syneos Health Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Syneos Health Recent Developments and Future Plans
2.24 INPHARMATIS
2.24.1 INPHARMATIS Details
2.24.2 INPHARMATIS Major Business
2.24.3 INPHARMATIS Pharmacovigilance Services Product and Solutions
2.24.4 INPHARMATIS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 INPHARMATIS Recent Developments and Future Plans
2.25 Taimei Technology
2.25.1 Taimei Technology Details
2.25.2 Taimei Technology Major Business
2.25.3 Taimei Technology Pharmacovigilance Services Product and Solutions
2.25.4 Taimei Technology Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Taimei Technology Recent Developments and Future Plans
2.26 Extedo
2.26.1 Extedo Details
2.26.2 Extedo Major Business
2.26.3 Extedo Pharmacovigilance Services Product and Solutions
2.26.4 Extedo Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Extedo Recent Developments and Future Plans
2.27 WCG Clinical
2.27.1 WCG Clinical Details
2.27.2 WCG Clinical Major Business
2.27.3 WCG Clinical Pharmacovigilance Services Product and Solutions
2.27.4 WCG Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 WCG Clinical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmacovigilance Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmacovigilance Services by Company Revenue
3.2.2 Top 3 Pharmacovigilance Services Players Market Share in 2022
3.2.3 Top 6 Pharmacovigilance Services Players Market Share in 2022
3.3 Pharmacovigilance Services Market: Overall Company Footprint Analysis
3.3.1 Pharmacovigilance Services Market: Region Footprint
3.3.2 Pharmacovigilance Services Market: Company Product Type Footprint
3.3.3 Pharmacovigilance Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pharmacovigilance Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmacovigilance Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Pharmacovigilance Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmacovigilance Services Market Forecast by Application (2024-2029)
6 North America
6.1 North America Pharmacovigilance Services Consumption Value by Type (2018-2029)
6.2 North America Pharmacovigilance Services Consumption Value by Application (2018-2029)
6.3 North America Pharmacovigilance Services Market Size by Country
6.3.1 North America Pharmacovigilance Services Consumption Value by Country (2018-2029)
6.3.2 United States Pharmacovigilance Services Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmacovigilance Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmacovigilance Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Pharmacovigilance Services Consumption Value by Type (2018-2029)
7.2 Europe Pharmacovigilance Services Consumption Value by Application (2018-2029)
7.3 Europe Pharmacovigilance Services Market Size by Country
7.3.1 Europe Pharmacovigilance Services Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmacovigilance Services Market Size and Forecast (2018-2029)
7.3.3 France Pharmacovigilance Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmacovigilance Services Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmacovigilance Services Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmacovigilance Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmacovigilance Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmacovigilance Services Market Size by Region
8.3.1 Asia-Pacific Pharmacovigilance Services Consumption Value by Region (2018-2029)
8.3.2 China Pharmacovigilance Services Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmacovigilance Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmacovigilance Services Market Size and Forecast (2018-2029)
8.3.5 India Pharmacovigilance Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmacovigilance Services Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmacovigilance Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America Pharmacovigilance Services Consumption Value by Type (2018-2029)
9.2 South America Pharmacovigilance Services Consumption Value by Application (2018-2029)
9.3 South America Pharmacovigilance Services Market Size by Country
9.3.1 South America Pharmacovigilance Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmacovigilance Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmacovigilance Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmacovigilance Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmacovigilance Services Market Size by Country
10.3.1 Middle East & Africa Pharmacovigilance Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmacovigilance Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmacovigilance Services Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmacovigilance Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Pharmacovigilance Services Market Drivers
11.2 Pharmacovigilance Services Market Restraints
11.3 Pharmacovigilance Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Pharmacovigilance Services Industry Chain
12.2 Pharmacovigilance Services Upstream Analysis
12.3 Pharmacovigilance Services Midstream Analysis
12.4 Pharmacovigilance Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Pharmacovigilance Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmacovigilance Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmacovigilance Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmacovigilance Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. PrimeVigilance Company Information, Head Office, and Major Competitors
Table 6. PrimeVigilance Major Business
Table 7. PrimeVigilance Pharmacovigilance Services Product and Solutions
Table 8. PrimeVigilance Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. PrimeVigilance Recent Developments and Future Plans
Table 10. Quanticate Company Information, Head Office, and Major Competitors
Table 11. Quanticate Major Business
Table 12. Quanticate Pharmacovigilance Services Product and Solutions
Table 13. Quanticate Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Quanticate Recent Developments and Future Plans
Table 15. ProPharma Company Information, Head Office, and Major Competitors
Table 16. ProPharma Major Business
Table 17. ProPharma Pharmacovigilance Services Product and Solutions
Table 18. ProPharma Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ProPharma Recent Developments and Future Plans
Table 20. Parexel Company Information, Head Office, and Major Competitors
Table 21. Parexel Major Business
Table 22. Parexel Pharmacovigilance Services Product and Solutions
Table 23. Parexel Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Parexel Recent Developments and Future Plans
Table 25. Accenture Company Information, Head Office, and Major Competitors
Table 26. Accenture Major Business
Table 27. Accenture Pharmacovigilance Services Product and Solutions
Table 28. Accenture Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Accenture Recent Developments and Future Plans
Table 30. SOTERIUS Company Information, Head Office, and Major Competitors
Table 31. SOTERIUS Major Business
Table 32. SOTERIUS Pharmacovigilance Services Product and Solutions
Table 33. SOTERIUS Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. SOTERIUS Recent Developments and Future Plans
Table 35. SGS Company Information, Head Office, and Major Competitors
Table 36. SGS Major Business
Table 37. SGS Pharmacovigilance Services Product and Solutions
Table 38. SGS Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. SGS Recent Developments and Future Plans
Table 40. Medpace Company Information, Head Office, and Major Competitors
Table 41. Medpace Major Business
Table 42. Medpace Pharmacovigilance Services Product and Solutions
Table 43. Medpace Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Medpace Recent Developments and Future Plans
Table 45. PPD Company Information, Head Office, and Major Competitors
Table 46. PPD Major Business
Table 47. PPD Pharmacovigilance Services Product and Solutions
Table 48. PPD Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. PPD Recent Developments and Future Plans
Table 50. QVigilance Company Information, Head Office, and Major Competitors
Table 51. QVigilance Major Business
Table 52. QVigilance Pharmacovigilance Services Product and Solutions
Table 53. QVigilance Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. QVigilance Recent Developments and Future Plans
Table 55. Freyr Solutions Company Information, Head Office, and Major Competitors
Table 56. Freyr Solutions Major Business
Table 57. Freyr Solutions Pharmacovigilance Services Product and Solutions
Table 58. Freyr Solutions Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Freyr Solutions Recent Developments and Future Plans
Table 60. Navitas Life Sciences Company Information, Head Office, and Major Competitors
Table 61. Navitas Life Sciences Major Business
Table 62. Navitas Life Sciences Pharmacovigilance Services Product and Solutions
Table 63. Navitas Life Sciences Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Navitas Life Sciences Recent Developments and Future Plans
Table 65. MMS Holdings Company Information, Head Office, and Major Competitors
Table 66. MMS Holdings Major Business
Table 67. MMS Holdings Pharmacovigilance Services Product and Solutions
Table 68. MMS Holdings Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. MMS Holdings Recent Developments and Future Plans
Table 70. Amarex Company Information, Head Office, and Major Competitors
Table 71. Amarex Major Business
Table 72. Amarex Pharmacovigilance Services Product and Solutions
Table 73. Amarex Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Amarex Recent Developments and Future Plans
Table 75. Astrix Technology Group Company Information, Head Office, and Major Competitors
Table 76. Astrix Technology Group Major Business
Table 77. Astrix Technology Group Pharmacovigilance Services Product and Solutions
Table 78. Astrix Technology Group Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Astrix Technology Group Recent Developments and Future Plans
Table 80. Cambridge Regulatory Services Company Information, Head Office, and Major Competitors
Table 81. Cambridge Regulatory Services Major Business
Table 82. Cambridge Regulatory Services Pharmacovigilance Services Product and Solutions
Table 83. Cambridge Regulatory Services Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Cambridge Regulatory Services Recent Developments and Future Plans
Table 85. CROMSOURCE Company Information, Head Office, and Major Competitors
Table 86. CROMSOURCE Major Business
Table 87. CROMSOURCE Pharmacovigilance Services Product and Solutions
Table 88. CROMSOURCE Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. CROMSOURCE Recent Developments and Future Plans
Table 90. APCER Life Sciences Company Information, Head Office, and Major Competitors
Table 91. APCER Life Sciences Major Business
Table 92. APCER Life Sciences Pharmacovigilance Services Product and Solutions
Table 93. APCER Life Sciences Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. APCER Life Sciences Recent Developments and Future Plans
Table 95. Pharmya Company Information, Head Office, and Major Competitors
Table 96. Pharmya Major Business
Table 97. Pharmya Pharmacovigilance Services Product and Solutions
Table 98. Pharmya Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Pharmya Recent Developments and Future Plans
Table 100. A+Science Company Information, Head Office, and Major Competitors
Table 101. A+Science Major Business
Table 102. A+Science Pharmacovigilance Services Product and Solutions
Table 103. A+Science Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. A+Science Recent Developments and Future Plans
Table 105. Midas Pharma Company Information, Head Office, and Major Competitors
Table 106. Midas Pharma Major Business
Table 107. Midas Pharma Pharmacovigilance Services Product and Solutions
Table 108. Midas Pharma Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Midas Pharma Recent Developments and Future Plans
Table 110. George Clinical Company Information, Head Office, and Major Competitors
Table 111. George Clinical Major Business
Table 112. George Clinical Pharmacovigilance Services Product and Solutions
Table 113. George Clinical Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. George Clinical Recent Developments and Future Plans
Table 115. Syneos Health Company Information, Head Office, and Major Competitors
Table 116. Syneos Health Major Business
Table 117. Syneos Health Pharmacovigilance Services Product and Solutions
Table 118. Syneos Health Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Syneos Health Recent Developments and Future Plans
Table 120. INPHARMATIS Company Information, Head Office, and Major Competitors
Table 121. INPHARMATIS Major Business
Table 122. INPHARMATIS Pharmacovigilance Services Product and Solutions
Table 123. INPHARMATIS Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. INPHARMATIS Recent Developments and Future Plans
Table 125. Taimei Technology Company Information, Head Office, and Major Competitors
Table 126. Taimei Technology Major Business
Table 127. Taimei Technology Pharmacovigilance Services Product and Solutions
Table 128. Taimei Technology Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Taimei Technology Recent Developments and Future Plans
Table 130. Extedo Company Information, Head Office, and Major Competitors
Table 131. Extedo Major Business
Table 132. Extedo Pharmacovigilance Services Product and Solutions
Table 133. Extedo Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Extedo Recent Developments and Future Plans
Table 135. WCG Clinical Company Information, Head Office, and Major Competitors
Table 136. WCG Clinical Major Business
Table 137. WCG Clinical Pharmacovigilance Services Product and Solutions
Table 138. WCG Clinical Pharmacovigilance Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. WCG Clinical Recent Developments and Future Plans
Table 140. Global Pharmacovigilance Services Revenue (USD Million) by Players (2018-2023)
Table 141. Global Pharmacovigilance Services Revenue Share by Players (2018-2023)
Table 142. Breakdown of Pharmacovigilance Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 143. Market Position of Players in Pharmacovigilance Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 144. Head Office of Key Pharmacovigilance Services Players
Table 145. Pharmacovigilance Services Market: Company Product Type Footprint
Table 146. Pharmacovigilance Services Market: Company Product Application Footprint
Table 147. Pharmacovigilance Services New Market Entrants and Barriers to Market Entry
Table 148. Pharmacovigilance Services Mergers, Acquisition, Agreements, and Collaborations
Table 149. Global Pharmacovigilance Services Consumption Value (USD Million) by Type (2018-2023)
Table 150. Global Pharmacovigilance Services Consumption Value Share by Type (2018-2023)
Table 151. Global Pharmacovigilance Services Consumption Value Forecast by Type (2024-2029)
Table 152. Global Pharmacovigilance Services Consumption Value by Application (2018-2023)
Table 153. Global Pharmacovigilance Services Consumption Value Forecast by Application (2024-2029)
Table 154. North America Pharmacovigilance Services Consumption Value by Type (2018-2023) & (USD Million)
Table 155. North America Pharmacovigilance Services Consumption Value by Type (2024-2029) & (USD Million)
Table 156. North America Pharmacovigilance Services Consumption Value by Application (2018-2023) & (USD Million)
Table 157. North America Pharmacovigilance Services Consumption Value by Application (2024-2029) & (USD Million)
Table 158. North America Pharmacovigilance Services Consumption Value by Country (2018-2023) & (USD Million)
Table 159. North America Pharmacovigilance Services Consumption Value by Country (2024-2029) & (USD Million)
Table 160. Europe Pharmacovigilance Services Consumption Value by Type (2018-2023) & (USD Million)
Table 161. Europe Pharmacovigilance Services Consumption Value by Type (2024-2029) & (USD Million)
Table 162. Europe Pharmacovigilance Services Consumption Value by Application (2018-2023) & (USD Million)
Table 163. Europe Pharmacovigilance Services Consumption Value by Application (2024-2029) & (USD Million)
Table 164. Europe Pharmacovigilance Services Consumption Value by Country (2018-2023) & (USD Million)
Table 165. Europe Pharmacovigilance Services Consumption Value by Country (2024-2029) & (USD Million)
Table 166. Asia-Pacific Pharmacovigilance Services Consumption Value by Type (2018-2023) & (USD Million)
Table 167. Asia-Pacific Pharmacovigilance Services Consumption Value by Type (2024-2029) & (USD Million)
Table 168. Asia-Pacific Pharmacovigilance Services Consumption Value by Application (2018-2023) & (USD Million)
Table 169. Asia-Pacific Pharmacovigilance Services Consumption Value by Application (2024-2029) & (USD Million)
Table 170. Asia-Pacific Pharmacovigilance Services Consumption Value by Region (2018-2023) & (USD Million)
Table 171. Asia-Pacific Pharmacovigilance Services Consumption Value by Region (2024-2029) & (USD Million)
Table 172. South America Pharmacovigilance Services Consumption Value by Type (2018-2023) & (USD Million)
Table 173. South America Pharmacovigilance Services Consumption Value by Type (2024-2029) & (USD Million)
Table 174. South America Pharmacovigilance Services Consumption Value by Application (2018-2023) & (USD Million)
Table 175. South America Pharmacovigilance Services Consumption Value by Application (2024-2029) & (USD Million)
Table 176. South America Pharmacovigilance Services Consumption Value by Country (2018-2023) & (USD Million)
Table 177. South America Pharmacovigilance Services Consumption Value by Country (2024-2029) & (USD Million)
Table 178. Middle East & Africa Pharmacovigilance Services Consumption Value by Type (2018-2023) & (USD Million)
Table 179. Middle East & Africa Pharmacovigilance Services Consumption Value by Type (2024-2029) & (USD Million)
Table 180. Middle East & Africa Pharmacovigilance Services Consumption Value by Application (2018-2023) & (USD Million)
Table 181. Middle East & Africa Pharmacovigilance Services Consumption Value by Application (2024-2029) & (USD Million)
Table 182. Middle East & Africa Pharmacovigilance Services Consumption Value by Country (2018-2023) & (USD Million)
Table 183. Middle East & Africa Pharmacovigilance Services Consumption Value by Country (2024-2029) & (USD Million)
Table 184. Pharmacovigilance Services Raw Material
Table 185. Key Suppliers of Pharmacovigilance Services Raw Materials
List of Figures
Figure 1. Pharmacovigilance Services Picture
Figure 2. Global Pharmacovigilance Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmacovigilance Services Consumption Value Market Share by Type in 2022
Figure 4. Adverse Event Case Management
Figure 5. Aggregate Reporting
Figure 6. Signal Intelligence
Figure 7. Risk Management
Figure 8. Global Pharmacovigilance Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Pharmacovigilance Services Consumption Value Market Share by Application in 2022
Figure 10. Biotechnology and Pharmaceuticals Picture
Figure 11. Contract Research Organization Picture
Figure 12. Hospital Picture
Figure 13. KPO / BPO Picture
Figure 14. Healthcare Institutions Picture
Figure 15. Others Picture
Figure 16. Global Pharmacovigilance Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Pharmacovigilance Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Pharmacovigilance Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Pharmacovigilance Services Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Pharmacovigilance Services Consumption Value Market Share by Region in 2022
Figure 21. North America Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pharmacovigilance Services Revenue Share by Players in 2022
Figure 27. Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Pharmacovigilance Services Market Share in 2022
Figure 29. Global Top 6 Players Pharmacovigilance Services Market Share in 2022
Figure 30. Global Pharmacovigilance Services Consumption Value Share by Type (2018-2023)
Figure 31. Global Pharmacovigilance Services Market Share Forecast by Type (2024-2029)
Figure 32. Global Pharmacovigilance Services Consumption Value Share by Application (2018-2023)
Figure 33. Global Pharmacovigilance Services Market Share Forecast by Application (2024-2029)
Figure 34. North America Pharmacovigilance Services Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Pharmacovigilance Services Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Pharmacovigilance Services Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Pharmacovigilance Services Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Pharmacovigilance Services Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Pharmacovigilance Services Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 44. France Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pharmacovigilance Services Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pharmacovigilance Services Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pharmacovigilance Services Consumption Value Market Share by Region (2018-2029)
Figure 51. China Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 54. India Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Pharmacovigilance Services Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Pharmacovigilance Services Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Pharmacovigilance Services Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Pharmacovigilance Services Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Pharmacovigilance Services Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Pharmacovigilance Services Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Pharmacovigilance Services Consumption Value (2018-2029) & (USD Million)
Figure 68. Pharmacovigilance Services Market Drivers
Figure 69. Pharmacovigilance Services Market Restraints
Figure 70. Pharmacovigilance Services Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Pharmacovigilance Services in 2022
Figure 73. Manufacturing Process Analysis of Pharmacovigilance Services
Figure 74. Pharmacovigilance Services Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source